The International Scientific Association for Probiotics and Prebiotics (ISAPP) consensus statement on the definition and scope of gut health
Wilmore, D. W. Metabolic support of the gastrointestinal tract: potential gut protection during intensive cytotoxic therapy. Cancer 79, 1794–1803 (1997).
Google Scholar
Coussement, P. A. A. Communicating about gut health to the consumer: presenting the BENEO Programme. Br. J. Nutr. 87, S301–S303 (2002).
Google Scholar
Williams, G. M., Tapsell, L. C. & Beck, E. J. Gut health, the microbiome and dietary choices: an exploration of consumer perspectives. Nutr. Diet. 80, 85–94 (2023).
Google Scholar
Bischoff, S. C. “Gut health”: a new objective in medicine? BMC Med. 9, 24 (2011). This viewpoint paper proposes a first definition of gut health and elaborates on criteria necessary for gut health and how to measure it.
Google Scholar
World Health Organization. Summary Report on Pproceedings, Minutes and Final Acts of the International Health Conference held in New York from 19 June to 22 July 1946 (WHO, 1948).
Staudacher, H. M. & Loughman, A. Gut health: definitions and determinants. Lancet Gastroenterol. Hepatol. 6, 269 (2021).
Google Scholar
van der Hee, B. & Wells, J. M. Microbial regulation of host physiology by short-chain fatty acids. Trends Microbiol. 29, 700–712 (2021).
Google Scholar
Roager, H. M. & Licht, T. R. Microbial tryptophan catabolites in health and disease. Nat. Commun. 9, 3294 (2018).
Google Scholar
Van Hul, M. et al. What defines a healthy gut microbiome? Gut 73, 1893–1908 (2024).
Google Scholar
Keely, S. J. & Barrett, K. E. Intestinal secretory mechanisms and diarrhea. Am. J. Physiol. Gastrointest. Liver Physiol. 322, G405–G420 (2022). This review provides an authoritative overview of intestinal secretion and how its disruption could lead to diarrhea.
Google Scholar
Hong, J. H., Park, S., Shcheynikov, N. & Muallem, S. Mechanism and synergism in epithelial fluid and electrolyte secretion. Pflug. Arch. 466, 1487–1499 (2014).
Google Scholar
Bishu, S. & Quigley, E. M. M. in Yamada’ s Textbook of Gastroenterology (eds Podolsky, D. K. et al.) 538–555 (Wiley, 2015).
Lankisch, P. G. Secretion and absorption (methods and functions). Best Pract. Res. Clin. Gastroenterol. 23, 325–335 (2009).
Google Scholar
Papadia, C., Di Sabatino, A., Corazza, G. R. & Forbes, A. Diagnosing small bowel malabsorption: a review. Intern. Emerg. Med. 9, 3–8 (2014).
Google Scholar
Camilleri, M., Sellin, J. H. & Barrett, K. E. Pathophysiology, evaluation, and management of chronic watery diarrhea. Gastroenterology 152, 515–532.e2 (2017).
Google Scholar
Omer, E. & Chiodi, C. Fat digestion and absorption: normal physiology and pathophysiology of malabsorption, including diagnostic testing. Nutr. Clin. Pract. 39, S6–S16 (2024).
Google Scholar
Lenti, M. V. et al. European consensus on malabsorption — UEG & SIGE, LGA, SPG, SRGH, CGS, ESPCG, EAGEN, ESPEN, and ESPGHAN. Part 2: screening, special populations, nutritional goals, supportive care, primary care perspective. United European Gastroenterol. J. 13, 773–797 (2025). A very recent and comprehensive discussion on malabsorption including a guide to screening and the identification of those most at risk of malabsorption.
Google Scholar
Pironi, L. Definitions of intestinal failure and the short bowel syndrome. Best Pract. Res. Clin. Gastroenterol. 30, 173–185 (2016).
Google Scholar
Camilleri, M., Hasler, W. L., Parkman, H. P., Quigley, E. M. & Soffer, E. Measurement of gastrointestinal motility in the GI laboratory. Gastroenterology 115, 747–762 (1998).
Google Scholar
Camilleri, M. et al. American Neurogastroenterology and Motility Society consensus statement on intraluminal measurement of gastrointestinal and colonic motility in clinical practice. Neurogastroenterol. Motil. 20, 1269–1282 (2008).
Google Scholar
Smout, A. J. P. M. & Mundt, M. W. Gastrointestinal motility testing. Best Pract. Res. Clin. Gastroenterol. 23, 287–298 (2009).
Google Scholar
Carrington, E. V. et al. The International Anorectal Physiology Working Group (IAPWG) recommendations: standardized testing protocol and the London classification for disorders of anorectal function. Neurogastroenterol. Motil. 32, e13679 (2020).
Google Scholar
Gyawali, C. P. et al. ACG clinical guidelines: clinical use of esophageal physiologic testing. Am. J. Gastroenterol. 115, 1412–1428 (2020).
Google Scholar
Odunsi, S. T. & Camilleri, M. Selected interventions in nuclear medicine: gastrointestinal motor functions. Semin. Nucl. Med. 39, 186–194 (2009).
Google Scholar
Yadlapati, R. et al. Esophageal motility disorders on high-resolution manometry: Chicago classification version 4.0. Neurogastroenterol. Motil. 33, e14058 (2021).
Google Scholar
Quigley, E. M. M. Review article: gastric emptying in functional gastrointestinal disorders. Aliment. Pharmacol. Ther. 20, 56–60 (2004).
Google Scholar
Pasricha, P. J. et al. Functional dyspepsia and gastroparesis in tertiary care are interchangeable syndromes with common clinical and pathologic features. Gastroenterology 160, 2006–2017 (2021).
Google Scholar
Bellini, M. et al. Irritable bowel syndrome and chronic constipation: fact and fiction. World J. Gastroenterol. 21, 11362–11370 (2015).
Google Scholar
Procházková, N. et al. Gut physiology and environment explain variations in human gut microbiome composition and metabolism. Nat. Microbiol. 9, 3210–3225 (2024). Wireless motility capsules and multi-omics showed substantial daily fluctuations in transit times and luminal pH among healthy individuals, and provided explanations for differences in gut microbiome metabolites.
Google Scholar
Claesson, M. J., Clooney, A. G. & O’Toole, P. W. A clinician’s guide to microbiome analysis. Nat. Rev. Gastroenterol. Hepatol. 14, 585–595 (2017).
Google Scholar
Costea, P. I. et al. Towards standards for human fecal sample processing in metagenomic studies. Nat. Biotechnol. 35, 1069–1076 (2017).
Google Scholar
Truong, D. T., Tett, A., Pasolli, E., Huttenhower, C. & Segata, N. Microbial strain-level population structure and genetic diversity from metagenomes. Genome Res. 27, 626–638 (2017).
Google Scholar
Falony, G. et al. Population-level analysis of gut microbiome variation. Science 352, 560–564 (2016). A pioneering study that ranks the effect size of common metadata variables upon microbiome variation and highlights that 92% of variation is unexplained.
Google Scholar
Claesson, M. J. et al. Gut microbiota composition correlates with diet and health in the elderly. Nature 488, 178–184 (2012).
Google Scholar
Ghosh, T. S., Shanahan, F. & O’Toole, P. W. The gut microbiome as a modulator of healthy ageing. Nat. Rev. Gastroenterol. Hepatol. 19, 565–584 (2022).
Google Scholar
Ghosh, T. S., Shanahan, F. & O’Toole, P. W. Toward an improved definition of a healthy microbiome for healthy aging. Nat. Aging 2, 1054–1069 (2022).
Google Scholar
O’Toole, P. W. et al. Translating the microbiome: what’s the target? Gastroenterology 165, 317–319 (2023).
Google Scholar
Shanahan, F., Ghosh, T. S. & O’Toole, P. W. The healthy microbiome — what is the definition of a healthy gut microbiome? Gastroenterology 160, 483–494 (2021).
Google Scholar
De Filippo, C. et al. Impact of diet in shaping gut microbiota revealed by a comparative study in children from Europe and rural Africa. Proc. Natl Acad. Sci. USA 107, 14691–14696 (2010).
Google Scholar
Duvallet, C., Gibbons, S. M., Gurry, T., Irizarry, R. A. & Alm, E. J. Meta-analysis of gut microbiome studies identifies disease-specific and shared responses. Nat. Commun. 8, 1784 (2017). One of the first studies to clearly show the extent of taxon overlap in microbiome variations from normal in many so-called dysbiosis-related diseases.
Google Scholar
Britton, R. A. et al. Taking microbiome science to the next level: recommendations to advance the emerging field of microbiome-based therapeutics and diagnostics. Gastroenterology 167, 1059–1064 (2024).
Google Scholar
Zhernakova, A. et al. Population-based metagenomics analysis reveals markers for gut microbiome composition and diversity. Science 352, 565–569 (2016).
Google Scholar
Tett, A., Pasolli, E., Masetti, G., Ercolini, D. & Segata, N. Prevotella diversity, niches and interactions with the human host. Nat. Rev. Microbiol. 19, 585–599 (2021).
Google Scholar
Fabbrini, M., Candela, M., Turroni, S., Brigidi, P. & Rampelli, S. Exploring clade differentiation of the Faecalibacterium prausnitzii complex. iScience 25, 105533 (2022).
Google Scholar
Karcher, N. et al. Analysis of 1321 Eubacterium rectale genomes from metagenomes uncovers complex phylogeographic population structure and subspecies functional adaptations. Genome Biol. 21, 138 (2020).
Google Scholar
Bäckhed, F. et al. Defining a healthy human gut microbiome: current concepts, future directions, and clinical applications. Cell Host Microbe 12, 611–622 (2012).
Google Scholar
Lloyd-Price, J., Abu-Ali, G. & Huttenhower, C. The healthy human microbiome. Genome Med. 8, 51 (2016).
Google Scholar
Eisenstein, M. The hunt for a healthy microbiome. Nature 577, S6–S8 (2020).
Google Scholar
Porcari, S. et al. International consensus statement on microbiome testing in clinical practice. Lancet Gastroenterol. Hepatol. 10, 154–167 (2025). In the face of runaway enthusiasm for microbiome testing from patients and some commentators, this measured commentary highlights that microbiome information is not yet clinically actionable to a degree that would pass regulatory review, but that applications are very close.
Google Scholar
Horowitz, A., Chanez-Paredes, S. D., Haest, X. & Turner, J. R. Paracellular permeability and tight junction regulation in gut health and disease. Nat. Rev. Gastroenterol. Hepatol. 20, 417–432 (2023).
Google Scholar
Neurath, M. F., Artis, D. & Becker, C. The intestinal barrier: a pivotal role in health, inflammation, and cancer. Lancet Gastroenterol. Hepatol. 10, 573–592 (2025). This recent review comprehensively discusses the importance of the intestinal barrier for intestinal health and for the development of diseases such as IBD, metabolic dysfunction-associated steatohepatitis and cancer.
Google Scholar
Drucker, D. J. Discovery of GLP-1-based drugs for the treatment of obesity. N. Engl. J. Med. 392, 612–615 (2025).
Google Scholar
Wells, J. M. et al. Homeostasis of the gut barrier and potential biomarkers. Am. J. Physiol. Gastrointest. Liver Physiol. 312, G171–G193 (2017).
Google Scholar
McGuckin, M. A., Lindén, S. K., Sutton, P. & Florin, T. H. Mucin dynamics and enteric pathogens. Nat. Rev. Microbiol. 9, 265–278 (2011).
Google Scholar
Zuo, L., Kuo, W.-T. & Turner, J. R. Tight junctions as targets and effectors of mucosal immune homeostasis. Cell. Mol. Gastroenterol. Hepatol. 10, 327–340 (2020).
Google Scholar
Fu, J. et al. Mechanisms and regulation of defensins in host defense. Signal Transduct. Target. Ther. 8, 300 (2023).
Google Scholar
Adolph, T. E., Mayr, L., Grabherr, F. & Tilg, H. Paneth cells and their antimicrobials in intestinal immunity. Curr. Pharm. Des. 24, 1121–1129 (2018).
Google Scholar
Okumura, R. et al. Lypd8 promotes the segregation of flagellated microbiota and colonic epithelia. Nature 532, 117–121 (2016).
Google Scholar
Wells, J. M., Rossi, O., Meijerink, M. & van Baarlen, P. Epithelial crosstalk at the microbiota–mucosal interface. Proc. Natl Acad. Sci. USA 108, 4607–4614 (2011).
Google Scholar
Canfora, E. E., Meex, R. C. R., Venema, K. & Blaak, E. E. Gut microbial metabolites in obesity, NAFLD and T2DM. Nat. Rev. Endocrinol. 15, 261–273 (2019).
Google Scholar
Scott, S. A., Fu, J. & Chang, P. V. Microbial tryptophan metabolites regulate gut barrier function via the aryl hydrocarbon receptor. Proc. Natl Acad. Sci. USA 117, 19376–19387 (2020).
Google Scholar
He, W.-Q. et al. Contributions of myosin light chain kinase to regulation of epithelial paracellular permeability and mucosal homeostasis. Int. J. Mol. Sci. 21, 993 (2020).
Google Scholar
Turner, J. R. Intestinal mucosal barrier function in health and disease. Nat. Rev. Immunol. 9, 799–809 (2009).
Google Scholar
Bischoff, S. C. et al. Intestinal permeability — a new target for disease prevention and therapy. BMC Gastroenterol. 14, 189 (2014).
Google Scholar
Camilleri, M. Leaky gut: mechanisms, measurement and clinical implications in humans. Gut 68, 1516–1526 (2019).
Google Scholar
Grover, M., Vanuytsel, T. & Chang, L. Intestinal permeability in disorders of gut–brain interaction: from bench to bedside. Gastroenterology 168, 480–495 (2025).
Google Scholar
Lacy, B. E., Wise, J. L. & Cangemi, D. J. Leaky gut syndrome: myths and management. Gastroenterol. Hepatol. 20, 264–272 (2024).
Pabst, O. & Mowat, A. M. Oral tolerance to food protein. Mucosal Immunol. 5, 232–239 (2012).
Google Scholar
Faria, A. M. C. & Weiner, H. L. Oral tolerance. Immunol. Rev. 206, 232–259 (2005).
Google Scholar
Cerovic, V., Pabst, O. & Mowat, A. M. The renaissance of oral tolerance: merging tradition and new insights. Nat. Rev. Immunol. 25, 42–56 (2025).
Google Scholar
Bouziat, R. et al. Reovirus infection triggers inflammatory responses to dietary antigens and development of celiac disease. Science 356, 44–50 (2017). This paper shows that an otherwise asymptomatic enteric reovirus infection can break oral tolerance to dietary antigens (including gluten) by inducing a type 1 inflammatory immune programme, thereby promoting a coeliac disease-like pathology.
Google Scholar
Medina Sanchez, L. et al. The gut protist Tritrichomonas arnold restrains virus-mediated loss of oral tolerance by modulating dietary antigen-presenting dendritic cells. Immunity 56, 1862–1875.e9 (2023).
Google Scholar
Arpaia, N. et al. Metabolites produced by commensal bacteria promote peripheral regulatory T-cell generation. Nature 504, 451–455 (2013). This study demonstrates that microbiota-derived SCFAs — particularly butyrate — directly promote extrathymic (peripheral) FOXP3⁺ Treg cell differentiation, establishing a causal link between bacterial metabolites and host immune tolerance.
Google Scholar
Kotas, M. E. & Medzhitov, R. Homeostasis, inflammation, and disease susceptibility. Cell 160, 816–827 (2015).
Google Scholar
Bouziat, R. et al. Murine norovirus infection induces TH1 inflammatory responses to dietary antigens. Cell Host Microbe 24, 677–688.e5 (2018).
Google Scholar
Jenkins, D. et al. Guidelines for the initial biopsy diagnosis of suspected chronic idiopathic inflammatory bowel disease. The British Society of Gastroenterology Initiative. J. Clin. Pathol. 50, 93–105 (1997).
Google Scholar
Villanacci, V., Antonelli, E., Geboes, K., Casella, G. & Bassotti, G. Histological healing in inflammatory bowel disease: a still unfulfilled promise. World J. Gastroenterol. 19, 968–978 (2013).
Google Scholar
Ishida, N. et al. C-reactive protein is superior to fecal biomarkers for evaluating colon-wide active inflammation in ulcerative colitis. Sci. Rep. 11, 12431 (2021).
Google Scholar
Anindita, B. et al. High levels of fecal calprotectin and C-reactive protein in patients with colitis. J. Med. Life 16, 48–51 (2023).
Google Scholar
Jukic, A., Bakiri, L., Wagner, E. F., Tilg, H. & Adolph, T. E. Calprotectin: from biomarker to biological function. Gut 70, 1978–1988 (2021).
Google Scholar
Siegmund, B. & Zeitz, M. Innate and adaptive immunity in inflammatory bowel disease. World J. Gastroenterol. 17, 3178–3183 (2011).
Google Scholar
Knight, V. & Sepiashvili, L. Cytokine testing and challenges for diagnostic and clinical monitoring use. J. Allergy Clin. Immunol. 155, 410–413 (2025).
Google Scholar
Gutiérrez-Vázquez, C. & Quintana, F. J. Regulation of the immune response by the aryl hydrocarbon receptor. Immunity 48, 19–33 (2018).
Google Scholar
Brüning, J. C. & Fenselau, H. Integrative neurocircuits that control metabolism and food intake. Science 381, eabl7398 (2023).
Google Scholar
Miedzybrodzka, E. L., Reimann, F. & Gribble, F. M. in From Obesity to Diabetes. Handbook of Experimental Pharmacology Vol. 274 (eds Eckel, J. & Clément, K.) 109–129 (Springer, 2022). An extensive and well-documented chapter describing the state of the art related to the link between the gut endocrine function and obesity.
Barton, J. R. et al. Enteroendocrine cell regulation of the gut-brain axis. Front. Neurosci. 17, 1272955 (2023).
Google Scholar
Hong, S.-H. & Choi, K. M. Gut hormones and appetite regulation. Curr. Opin. Endocrinol. Diabetes Obes. 31, 115–121 (2024).
Google Scholar
Spreckley, E. & Murphy, K. G. The L-cell in nutritional sensing and the regulation of appetite. Front. Nutr. 2, 23 (2015).
Google Scholar
Schalla, M. A., Taché, Y. & Stengel, A. Neuroendocrine peptides of the gut and their role in the regulation of food intake. Compr. Physiol. 11, 1679–1730 (2021).
Google Scholar
Krieger, J.-P. Intestinal glucagon-like peptide-1 effects on food intake: physiological relevance and emerging mechanisms. Peptides 131, 170342 (2020).
Google Scholar
Angelini, G., Russo, S. & Mingrone, G. Incretin hormones, obesity and gut microbiota. Peptides 178, 171216 (2024).
Google Scholar
Drucker, D. J. & Yusta, B. Physiology and pharmacology of the enteroendocrine hormone glucagon-like peptide-2. Annu. Rev. Physiol. 76, 561–583 (2014).
Google Scholar
Chao, J., Coleman, R. A., Keating, D. J. & Martin, A. M. Gut microbiome regulation of gut hormone secretion. Endocrinology 166, bqaf004 (2025).
Google Scholar
Van Hul, M. & Cani, P. D. The gut microbiota in obesity and weight management: microbes as friends or foe? Nat. Rev. Endocrinol. 19, 258–271 (2023). A well-illustrated review explaining the rationale for considering the gut microbiota as a key player in the modulation of gut endocrine function in the context of obesity.
Google Scholar
Trzaskalski, N. A., Fadzeyeva, E. & Mulvihill, E. E. Dipeptidyl peptidase-4 at the interface between inflammation and metabolism. Clin. Med. Insights Endocrinol. Diabetes 13, 1179551420912972 (2020).
Google Scholar
Rhee, S. H., Pothoulakis, C. & Mayer, E. A. Principles and clinical implications of the brain-gut-enteric microbiota axis. Nat. Rev. Gastroenterol. Hepatol. 6, 306–314 (2009).
Google Scholar
Cryan, J. F. et al. The microbiota–gut–brain axis. Physiol. Rev. 99, 1877–2013 (2019).
Google Scholar
Alhadeff, A. L. & Yapici, N. Interoception and gut–brain communication. Curr. Biol. 34, R1125–R1130 (2024).
Google Scholar
Soliz-Rueda, J. R. et al. Gut microbiota and eating behaviour in circadian syndrome. Trends Endocrinol. Metab. 36, 15–28 (2025).
Google Scholar
Han, W. et al. A neural circuit for gut-induced reward. Cell 175, 665–678.e23 (2018).
Google Scholar
Kaelberer, M. M. et al. A gut–brain neural circuit for nutrient sensory transduction. Science 361, eaat5236 (2018).
Google Scholar
Balsiger, L. M., Carbone, F., Raymenants, K., Scarpellini, E. & Tack, J. Understanding and managing patients with overlapping disorders of gut–brain interaction. Lancet Gastroenterol. Hepatol. 8, 383–390 (2023).
Google Scholar
Leigh, S.-J. et al. The impact of acute and chronic stress on gastrointestinal physiology and function: a microbiota–gut–brain axis perspective. J. Physiol. 601, 4491–4538 (2023).
Google Scholar
Wilmes, L. et al. Sex specific gut–microbiota signatures of resilient and comorbid gut–brain phenotypes induced by early life stress. Neurobiol. Stress. 33, 100686 (2024).
Google Scholar
Schneider, K. M. et al. The enteric nervous system relays psychological stress to intestinal inflammation. Cell 186, 2823–2838.e20 (2023).
Google Scholar
Chang, H. et al. Stress-sensitive neural circuits change the gut microbiome via duodenal glands. Cell 187, 5393–5412.e30 (2024). A recent reminder that the gut–brain axis is a two-way system, identifying a neural circuit linking the experience of psychological stress to bacterial homeostasis and host defence via duodenal glands.
Google Scholar
Gheorghe, C. E. et al. The microbiota drives diurnal rhythms in tryptophan metabolism in the stressed gut. Cell Rep. 43, 114079 (2024).
Google Scholar
Cryan, J. F., Clarke, G., Dinan, T. G. & Schellekens, H. A microbial drugstore for motility. Cell Host Microbe 23, 691–692 (2018).
Google Scholar
Bhattarai, Y. et al. Gut microbiota-produced tryptamine activates an epithelial G-protein-coupled receptor to increase colonic secretion. Cell Host Microbe 23, 775–785.e5 (2018). An important example of how bacteria-derived metabolites can have direct effects on host physiology via specific host pharmacological targets to affect gastrointestinal motility.
Google Scholar
Clarke, G. et al. The microbiome–gut–brain axis during early life regulates the hippocampal serotonergic system in a sex-dependent manner. Mol. Psychiatry 18, 666–673 (2013).
Google Scholar
Dalile, B., Vervliet, B., Bergonzelli, G., Verbeke, K. & Van Oudenhove, L. Colon-delivered short-chain fatty acids attenuate the cortisol response to psychosocial stress in healthy men: a randomized, placebo-controlled trial. Neuropsychopharmacology 45, 2257–2266 (2020).
Google Scholar
Sudo, N. et al. Postnatal microbial colonization programs the hypothalamic-pituitary-adrenal system for stress response in mice. J. Physiol. 558, 263–275 (2004). A pivotal report outlining the key role of the gut microbiome in gut-to-brain signalling, linking a key component of gut health to postnatal development of the hypothalamic–pituitary–adrenal stress response in mice.
Google Scholar
Tofani, G. S. S. et al. Gut microbiota regulates stress responsivity via the circadian system. Cell Metab. 37, 138–153.e5 (2025).
Google Scholar
Clarke, G., Quigley, E. M. M., Cryan, J. F. & Dinan, T. G. Irritable bowel syndrome: towards biomarker identification. Trends Mol. Med. 15, 478–489 (2009).
Google Scholar
Gururajan, A., Clarke, G., Dinan, T. G. & Cryan, J. F. Molecular biomarkers of depression. Neurosci. Biobehav. Rev. 64, 101–133 (2016).
Google Scholar
Tielemans, M. M. et al. Gastrointestinal symptoms are still prevalent and negatively impact health-related quality of life: a large cross-sectional population based study in The Netherlands. PLoS ONE 8, e69876 (2013).
Google Scholar
Hunt, R. et al. Coping with common gastrointestinal symptoms in the community: a global perspective on heartburn, constipation, bloating, and abdominal pain/discomfort May 2013. J. Clin. Gastroenterol. 48, 567–578 (2014).
Google Scholar
Oh, J. E., Chey, W. D. & Spiegel, B. Abdominal bloating in the United States: results of a survey of 88,795 Americans examining prevalence and healthcare seeking. Clin. Gastroenterol. Hepatol. 21, 2370–2377 (2023).
Google Scholar
Wiklund, I., Carlsson, J. & Vakil, N. Gastroesophageal reflux symptoms and well-being in a random sample of the general population of a Swedish community. Am. J. Gastroenterol. 101, 18–28 (2006).
Google Scholar
Grosen, A. K. et al. Gastrointestinal symptoms and bowel habits in 53 046 healthy Danish blood donors: a nationwide cross-sectional study. BMJ Open Gastroenterol. 12, e001518 (2025). This study illustrates just how common occasional gastrointestinal symptoms are in the general population.
Google Scholar
Lemay, D. G. et al. Technician-scored stool consistency spans the full range of the Bristol scale in a healthy US population and differs by diet and chronic stress load. J. Nutr. 151, 1443–1452 (2021).
Google Scholar
Panigrahi, M. K., Kar, S. K., Singh, S. P. & Ghoshal, U. C. Defecation frequency and stool form in a coastal eastern Indian population. J. Neurogastroenterol. Motil. 19, 374–380 (2013).
Google Scholar
Colomier, E., Algera, J. P., Van den Houte, K., Simrén, M. & Tack, J. Mechanisms underlying food-related symptoms in disorders of gut–brain interaction: course ahead in research and clinical practice. Best Pract. Res. Clin. Gastroenterol. 62–63, 101824 (2023).
Google Scholar
Colomier, E. et al. Global prevalence and burden of meal-related abdominal pain. BMC Med. 20, 71 (2022).
Google Scholar
Judkins, T. C., Dennis-Wall, J. C., Sims, S. M., Colee, J. & Langkamp-Henken, B. Stool frequency and form and gastrointestinal symptoms differ by day of the menstrual cycle in healthy adult women taking oral contraceptives: a prospective observational study. BMC Womens Health 20, 136 (2020).
Google Scholar
Bernstein, M. T. et al. Gastrointestinal symptoms before and during menses in healthy women. BMC Womens Health 14, 14 (2014).
Google Scholar
Tack, J., Carbone, F., Chang, L. & Lacy, B. E. Patient-reported outcomes in disorders of gut–brain interaction. Gastroenterology 166, 572–587.e1 (2024). An overview of patient-reported outcomes for evaluating functional dyspepsia, IBS and chronic constipation.
Google Scholar
Lee, J., Lee, E.-H. & Moon, S. H. A systematic review of measurement properties of the instruments measuring health-related quality of life in patients with irritable bowel syndrome. Qual. Life Res. 25, 2985–2995 (2016).
Google Scholar
Borgaonkar, M. R. & Irvine, E. J. Quality of life measurement in gastrointestinal and liver disorders. Gut 47, 444–454 (2000).
Google Scholar
Coitinho Biurra, Y. et al. Symptom bothersomeness and life interference support Rome clinical criteria as clinically relevant indicators of DGBI. Neurogastroenterol. Motil. 36, e14936 (2024).
Google Scholar
Sperber, A. D. et al. Worldwide prevalence and burden of functional gastrointestinal disorders, results of Rome Foundation Global Study. Gastroenterology 160, 99–114.e3 (2021). The first global study of the prevalence of disorders of gut–brain interaction (formerly functional gastrointestinal disorders); it reveals that these disorders are very common worldwide, an observation that provides further evidence for the high frequency of gastrointestinal symptoms in the community.
Google Scholar
Vakil, N. et al. The Montreal definition and classification of gastroesophageal reflux disease: a global evidence-based consensus. Am. J. Gastroenterol. 101, 1900–1920 (2006).
Google Scholar
Drossman, D. A. et al. Rome IV. Functional Gastrointestinal Disorders: Disorders of Gut-Brain Interaction 4 edn (Rome Foundation, 2016).
Kindt, S., Coulie, B., Wajs, E., Janssens, J. & Tack, J. Reproducibility and symptomatic predictors of a slow nutrient drinking test in health and in functional dyspepsia. Neurogastroenterol. Motil. 20, 320–329 (2008).
Google Scholar
[No authors listed] Persistent diarrhoea in children in developing countries: memorandum from a WHO meeting. Bull. World Health Organ. 66, 709–717 (1988).
Rao, S. S. C. et al. Recognizing and defining occasional constipation: expert consensus recommendations. Am. J. Gastroenterol. 117, 1753–1758 (2022).
Google Scholar
Lewis, S. J. & Heaton, K. W. Stool form scale as a useful guide to intestinal transit time. Scand. J. Gastroenterol. 32, 920–924 (1997).
Google Scholar
Camilleri, M., Kerstens, R., Rykx, A. & Vandeplassche, L. A placebo-controlled trial of prucalopride for severe chronic constipation. N. Engl. J. Med. 358, 2344–2354 (2008).
Google Scholar
Fried, M. et al. Efficacy of tegaserod in chronic constipation in men. Am. J. Gastroenterol. 102, 362–370 (2007).
Google Scholar
Moudgal, R., Schultz, A. W. & Shah, E. D. Systemic disease associations with disorders of gut–brain interaction and gastrointestinal transit: a review. Clin. Exp. Gastroenterol. 14, 249–257 (2021).
Google Scholar
Alrefaai, L., Cade, J. E. & Burley, V. J. Dietary fibre intake and constipation in the UK Women’s Cohort Study. Proc. Nutr. Soc. 72, E287 (2013).
Google Scholar
Aune, D., Sen, A., Norat, T. & Riboli, E. Dietary fibre intake and the risk of diverticular disease: a systematic review and meta-analysis of prospective studies. Eur. J. Nutr. 59, 421–432 (2020).
Google Scholar
Reynolds, A. et al. Carbohydrate quality and human health: a series of systematic reviews and meta-analyses. Lancet 393, 434–445 (2019).
Google Scholar
van der Schoot, A., Drysdale, C., Whelan, K. & Dimidi, E. The effect of fiber supplementation on chronic constipation in adults: an updated systematic review and meta-analysis of randomized controlled trials. Am. J. Clin. Nutr. 116, 953–969 (2022).
Google Scholar
Moayyedi, P. et al. The effect of fiber supplementation on irritable bowel syndrome: a systematic review and meta-analysis. Am. J. Gastroenterol. 109, 1367–1374 (2014).
Google Scholar
Seethaler, B. et al. Effect of the Mediterranean diet on the faecal long-chain fatty acid composition and intestinal barrier integrity: an exploratory analysis of the randomised controlled LIBRE trial. Br. J. Nutr. 132, 1152–1160 (2024).
Google Scholar
Li, F. et al. Cardiometabolic benefits of a non-industrialized-type diet are linked to gut microbiome modulation. Cell 188, 1226–1247.e18 (2025).
Google Scholar
Pilichiewicz, A. N. et al. Functional dyspepsia is associated with a greater symptomatic response to fat but not carbohydrate, increased fasting and postprandial CCK, and diminished PYY. Am. J. Gastroenterol. 103, 2613–2623 (2008).
Google Scholar
Simrén, M., Agerforz, P., Björnsson, E. S. & Abrahamsson, H. Nutrient-dependent enhancement of rectal sensitivity in irritable bowel syndrome (IBS). Neurogastroenterol. Motil. 19, 20–29 (2007).
Google Scholar
Whelan, K., Bancil, A. S., Lindsay, J. O. & Chassaing, B. Ultra-processed foods and food additives in gut health and disease. Nat. Rev. Gastroenterol. Hepatol. 21, 406–427 (2024). A critical review of the evidence for the effects of ultraprocessed foods and food additives on gut health and disease.
Google Scholar
Fitzpatrick, J. A., Gibson, P. R., Taylor, K. M. & Halmos, E. P. The effect of dietary emulsifiers and thickeners on intestinal barrier function and its response to acute stress in healthy adult humans: a randomised controlled feeding study. Aliment. Pharmacol. Ther. 60, 863–875 (2024).
Google Scholar
Chassaing, B. et al. Randomized controlled-feeding study of dietary emulsifier carboxymethylcellulose reveals detrimental impacts on the gut microbiota and metabolome. Gastroenterology 162, 743–756 (2022).
Google Scholar
Bhattacharyya, S. et al. A randomized trial of the effects of the no-carrageenan diet on ulcerative colitis disease activity. Nutr. Healthy Aging 4, 181–192 (2017).
Google Scholar
Carr, P. R., Walter, V., Brenner, H. & Hoffmeister, M. Meat subtypes and their association with colorectal cancer: systematic review and meta-analysis. Int. J. Cancer 138, 293–302 (2016).
Google Scholar
Ferrucci, L. M. et al. Meat consumption and the risk of incident distal colon and rectal adenoma. Br. J. Cancer 106, 608–616 (2012).
Google Scholar
GBD 2019 Risk Factors Collaborators Global burden of 87 risk factors in 204 countries and territories, 1990-2019: a systematic analysis for the Global Burden of Disease Study 2019. Lancet 396, 1223–1249 (2020).
Google Scholar
Lescinsky, H. et al. Health effects associated with consumption of unprocessed red meat: a burden of proof study. Nat. Med. 28, 2075–2082 (2022).
Google Scholar
Ross, F. C. et al. The interplay between diet and the gut microbiome: implications for health and disease. Nat. Rev. Microbiol. 22, 671–686 (2024).
Google Scholar
Itsiopoulos, C., Mayr, H. L. & Thomas, C. J. The anti-inflammatory effects of a Mediterranean diet: a review. Curr. Opin. Clin. Nutr. Metab. Care 25, 415–422 (2022).
Google Scholar
Koelman, L., Egea Rodrigues, C. & Aleksandrova, K. Effects of dietary patterns on biomarkers of inflammation and immune responses: a systematic review and meta-analysis of randomized controlled trials. Adv. Nutr. 13, 101–115 (2022).
Google Scholar
Yao, C. K., Fitzpatrick, J., Machado, P. & Staudacher, H. M. Is there an “optimal” diet for prevention of inflammatory bowel disease? JGH Open 8, e70016 (2024).
Google Scholar
Wong, S. H. & Yu, J. Gut microbiota in colorectal cancer: mechanisms of action and clinical applications. Nat. Rev. Gastroenterol. Hepatol. 16, 690–704 (2019).
Google Scholar
Staudacher, H. M. & George, E. S. The Mediterranean diet for gastrointestinal conditions — premature or panacea? Lancet Gastroenterol. Hepatol. 9, 598 (2024).
Google Scholar
Black, C. J., Staudacher, H. M. & Ford, A. C. Efficacy of a low FODMAP diet in irritable bowel syndrome: systematic review and network meta-analysis. Gut 71, 1117–1126 (2022).
Google Scholar
So, D., Loughman, A. & Staudacher, H. M. Effects of a low FODMAP diet on the colonic microbiome in irritable bowel syndrome: a systematic review with meta-analysis. Am. J. Clin. Nutr. 116, 943–952 (2022). This systematic review demonstrates the clinically significant beneficial effects of a low FODMAP diet for the cardinal symptoms of IBS.
Google Scholar
David, L. A. et al. Diet rapidly and reproducibly alters the human gut microbiome. Nature 505, 559–563 (2014). A landmark study providing first compelling evidence that short-term extreme dietary change can rapidly reshape the human gut microbiome, providing further support for diet as a key modulator of gut health.
Google Scholar
Wu, G. D. et al. Linking long-term dietary patterns with gut microbial enterotypes. Science 334, 105–108 (2011).
Google Scholar
Healey, G. et al. Habitual dietary fibre intake influences gut microbiota response to an inulin-type fructan prebiotic: a randomised, double-blind, placebo-controlled, cross-over, human intervention study. Br. J. Nutr. 119, 176–189 (2018).
Google Scholar
Holscher, H. D. et al. Agave inulin supplementation affects the fecal microbiota of healthy adults participating in a randomized, double-blind, placebo-controlled, crossover trial. J. Nutr. 145, 2025–2032 (2015).
Google Scholar
Whelan, K., Ford, A. C., Burton-Murray, H. & Staudacher, H. M. Dietary management of irritable bowel syndrome: considerations, challenges, and solutions. Lancet Gastroenterol. Hepatol. 9, 1147–1161 (2024).
Google Scholar
Bai, X. et al. Cigarette smoke promotes colorectal cancer through modulation of gut microbiota and related metabolites. Gut 71, 2439–2450 (2022).
Google Scholar
Dziewiecka, H. et al. Physical activity induced alterations of gut microbiota in humans: a systematic review. BMC Sports Sci. Med. Rehabil. 14, 122 (2022).
Google Scholar
Gao, R. et al. Exercise therapy in patients with constipation: a systematic review and meta-analysis of randomized controlled trials. Scand. J. Gastroenterol. 54, 169–177 (2019).
Google Scholar
Nunan, D. et al. Physical activity for treatment of irritable bowel syndrome. Cochrane Database Syst. Rev. 6, CD011497 (2022).
Google Scholar
Bi, L. & Triadafilopoulos, G. Exercise and gastrointestinal function and disease: an evidence-based review of risks and benefits. Clin. Gastroenterol. Hepatol. 1, 345–355 (2003).
Google Scholar
Hawley, J. A., Forster, S. C. & Giles, E. M. Exercise, the gut microbiome and gastrointestinal diseases: therapeutic impact and molecular mechanisms. Gastroenterology 169, 48–62 (2025).
Google Scholar
Thaiss, C. A. A microbiome exercise. Science 381, 38 (2023).
Google Scholar
Young, J. European market developments in prebiotic- and probiotic-containing foodstuffs. Br. J. Nutr. 80, S231–S233 (1998).
Google Scholar
Marteau, P., Seksik, P. & Jian, R. Probiotics and intestinal health effects: a clinical perspective. Br. J. Nutr. 88, S51–S57 (2002).
Google Scholar
Rastall, R. A. Functional oligosaccharides: application and manufacture. Annu. Rev. Food Sci. Technol. 1, 305–339 (2010).
Google Scholar
Krumbeck, J. A., Maldonado-Gomez, M. X., Ramer-Tait, A. E. & Hutkins, R. W. Prebiotics and synbiotics: dietary strategies for improving gut health. Curr. Opin. Gastroenterol. 32, 110–119 (2016).
Google Scholar
Farsi, D. N. et al. Substituting meat for mycoprotein reduces genotoxicity and increases the abundance of beneficial microbes in the gut: Mycomeat, a randomised crossover control trial. Eur. J. Nutr. 62, 1479–1492 (2023).
Google Scholar
Moon, J. M. et al. Impact of glucosamine supplementation on gut health. Nutrients 13, 2180 (2021).
Google Scholar
Walsh, K. et al. Legume-supplemented feed for children hospitalised with severe malnutrition: a phase II trial. Br. J. Nutr. 132, 372–381 (2024).
Google Scholar
Ried, K., Travica, N., Dorairaj, R. & Sali, A. Herbal formula improves upper and lower gastrointestinal symptoms and gut health in Australian adults with digestive disorders. Nutr. Res. 76, 37–51 (2020).
Google Scholar
Dawson, S. L. A gut-focused perinatal dietary intervention is associated with lower alpha diversity of the infant gut microbiota: results from a randomised controlled trial. Nutr. Neurosci. 28, 694–708 (2025).
Google Scholar
Meloncelli, N. et al. Preventing gestational diabetes with a healthy gut diet: protocol for a pilot, feasibility randomized controlled trial. Nutrients 15, 4653 (2023).
Google Scholar
Ebell, M. H. et al. Strength of recommendation taxonomy (SORT): a patient-centered approach to grading evidence in the medical literature. Am. Fam. Physician 69, 548–556 (2004).
Google Scholar
Aparicio Rodrigo, M. et al. How to develop and evaluate consensus documents: methods and checklists. An. Pediatr. 103, 503890 (2025).
Google Scholar
Kameda, T., Toyokawa, W. & Tindale, R. S. Information aggregation and collective intelligence beyond the wisdom of crowds. Nat. Rev. Psychol. 1, 345–357 (2022).
Google Scholar
Joos, R. et al. Examining the healthy human microbiome concept. Nat. Rev. Microbiol. 23, 192–205 (2025).
Google Scholar
Biomarkers Definitions Working Group Biomarkers and surrogate endpoints: preferred definitions and conceptual framework. Clin. Pharmacol. Ther. 69, 89–95 (2001).
Google Scholar
Williamson, P. R. et al. The COMET Handbook: version 1.0. Trials 18, 280 (2017).
Google Scholar
Lam, K. W. & Leeds, J. How to manage: patient with a low faecal elastase. Frontline Gastroenterol. 12, 67–73 (2021).
Google Scholar
Khoshbin, K. et al. Development and validation of test for “leaky gut” small intestinal and colonic permeability using sugars in healthy adults. Gastroenterology 161, 463–475.e13 (2021).
Google Scholar
Rao, A. S. et al. Urine sugars for in vivo gut permeability: validation and comparisons in irritable bowel syndrome-diarrhea and controls. Am. J. Physiol. Gastrointest. Liver Physiol. 301, G919–G928 (2011).
Google Scholar
Seethaler, B. et al. Biomarkers for assessment of intestinal permeability in clinical practice. Am. J. Physiol. Gastrointest. Liver Physiol. 321, G11–G17 (2021).
Google Scholar
Kapel, N., Ouni, H., Benahmed, N. A. & Barbot-Trystram, L. Fecal calprotectin for the diagnosis and management of inflammatory bowel diseases. Clin. Transl. Gastroenterol. 14, e00617 (2023).
Google Scholar
Pruessner, J. C. et al. Free cortisol levels after awakening: a reliable biological marker for the assessment of adrenocortical activity. Life Sci. 61, 2539–2549 (1997).
Google Scholar
Cohen, S. & Janicki-Deverts, D. Who’s stressed? Distributions of psychological stress in the United States in probability samples from 1983, 2006, and 2009. J. Appl. Soc. Psychol. 42, 1320–1334 (2012).
Google Scholar
Metri, N.-J., Butt, A. S., Murali, A., Steiner-Lim, G. Z. & Lim, C. K. Normative data on serum and plasma tryptophan and kynurenine concentrations from 8089 individuals across 120 studies: a systematic review and meta-analysis. Int. J. Tryptophan Res. 16, 11786469231211184 (2023).
Google Scholar
Gheorghe, C. E. et al. Focus on the essentials: tryptophan metabolism and the microbiome–gut–brain axis. Curr. Opin. Pharmacol. 48, 137–145 (2019).
Google Scholar
Valles-Colomer, M. et al. The neuroactive potential of the human gut microbiota in quality of life and depression. Nat. Microbiol. 4, 623–632 (2019).
Google Scholar
Spichak, S. et al. Mining microbes for mental health: determining the role of microbial metabolic pathways in human brain health and disease. Neurosci. Biobehav. Rev. 125, 698–761 (2021).
Google Scholar
Wu, G. et al. A core microbiome signature as an indicator of health. Cell 187, 6550–6565.e11 (2024). Identifies a core microbiome signature based on stable genome interactions, organized into two competing guilds, as a holistic indicator of health and a predictor of disease and therapeutic outcomes.
Google Scholar
Frioux, C. et al. Enterosignatures define common bacterial guilds in the human gut microbiome. Cell Host Microbe 31, 1111–1125.e6 (2023).
Google Scholar
Goel, A. et al. Toward a health-associated core keystone index for the human gut microbiome. Cell Rep. 44, 115378 (2025).
Google Scholar
Tannock, G. W. Scoring microbiota function: a proposal to use features of evolutionary, symbiotic innovation to recognize a “healthy” human gut microbiota. Gut Microbes Rep. (2024).
Google Scholar
Le Roy, C. I. et al. Red wine consumption associated with increased gut microbiota α-diversity in 3 independent cohorts. Gastroenterology 158, 270–272.e2 (2020).
Google Scholar
Imhann, F. et al. Interplay of host genetics and gut microbiota underlying the onset and clinical presentation of inflammatory bowel disease. Gut 67, 108–119 (2018).
Google Scholar
Gois, M. F. B. et al. Impact of occupational pesticide exposure on the human gut microbiome. Front. Microbiol. 14, 1223120 (2023).
Google Scholar
Wastyk, H. C. et al. Gut-microbiota-targeted diets modulate human immune status. Cell 184, 4137–4153.e14 (2021).
Google Scholar
Wilmanski, T. et al. Gut microbiome pattern reflects healthy ageing and predicts survival in humans. Nat. Metab. 3, 274–286 (2021).
Google Scholar
Chang, D. et al. Gut microbiome wellness index 2 enhances health status prediction from gut microbiome taxonomic profiles. Nat. Commun. 15, 7447 (2024).
Google Scholar
Hickman, B. et al. Gut microbiota wellbeing index predicts overall health in a cohort of 1000 infants. Nat. Commun. 15, 8323 (2024). Describes predictable gut microbiota development in early life and introduces a well-being index based on healthy trajectories that predicts general health outcomes over the first 5 years of life.
Google Scholar
Cotillard, A. et al. Dietary intervention impact on gut microbial gene richness. Nature 500, 585–588 (2013).
Google Scholar
Qin, N. et al. Alterations of the human gut microbiome in liver cirrhosis. Nature 513, 59–64 (2014).
Google Scholar
Routy, B. et al. Gut microbiome influences efficacy of PD-1-based immunotherapy against epithelial tumors. Science 359, 91–97 (2018).
Google Scholar
Sharkey, K. A. & Mawe, G. M. The enteric nervous system. Physiol. Rev. 103, 1487–1564 (2023).
Google Scholar
Wilmes, L. et al. Of bowels, brain and behavior: a role for the gut microbiota in psychiatric comorbidities in irritable bowel syndrome. Neurogastroenterol. Motil. 33, e14095 (2021).
Google Scholar
Bonaz, B., Bazin, T. & Pellissier, S. The vagus nerve at the interface of the microbiota–gut–brain axis. Front. Neurosci. 12, 49 (2018).
Google Scholar
Fülling, C., Dinan, T. G. & Cryan, J. F. Gut microbe to brain signaling: what happens in vagus… Neuron 101, 998–1002 (2019).
Google Scholar
link
:max_bytes(150000):strip_icc()/Health-GettyImages-2222718735-eccdfcbd45b04d8fa98ecdad691be69c.jpg "6 Signs Your Gut Health Is Out of Balance")
